In organ-on-chip models, the coating of biochip membranes plays a central role in creating a biologically relevant interface between cells and the device. Whether the model uses established cell lines, stem cells, patient-derived samples, primary cells, spheroids, or organoids, the membrane surface must provide the appropriate extracellular matrix cues to support cell attachment, survival, differentiation, and tissue-specific function.

Choosing the right coating is therefore not simply a question of surface compatibility, but of matching the membrane environment to the biological needs of the chosen cell source and the intended organ-on-chip application. Different coatings may be required to support barrier formation, vascularization, long-term culture, or three-dimensional tissue organization, making coating selection a critical step in building reliable and physiologically meaningful organ-on-chip models.

What are the primary functions of a biochip coating?

In organ-on-chip models, membrane coatings are not just a preparatory step before cell seeding; they define the biological interface that allows cells to recognize an otherwise synthetic device surface as a tissue-like environment. Coating with extracellular matrix proteins in organ models is essential for cell attachment, spreading, orientation, protein expression, differentiation, and long-term viability. On porous membranes, coatings also help recreate basement-membrane-like cues, enabling epithelial, endothelial, and stromal cells to form organized layers, establish apical-basal polarity, and develop more physiologically relevant barrier properties.

Coatings are also used to tune how organ models respond to mechanical and biochemical stimuli. In perfused biochips, extracellular matrix coatings help cells remain anchored under flow and support shear-stress-dependent behavior, such as endothelial alignment and vascular barrier maturation. In tissue-barrier models, coating choice influences permeability, tight-junction formation, immune-cell interaction, and drug transport across the membrane. For stem-cell-, organoid-, spheroid-, and patient-derived models, biologically rich or tissue-specific coatings provide survival and differentiation cues that support maturation, 3D organization, and disease-relevant phenotypes. In this sense, the primary function of a coating is to translate the biochip membrane from an inert scaffold into an instructive microenvironment that controls adhesion, tissue architecture, barrier function, mechanotransduction, and model reproducibility.

Choosing the Right Coating for Your Organ-on-a-Chip

Organ-on-chip systems provide the biochips, pumps and consumables, but it is the surface coating that brings an organ model to life. Without a biocompatible interface, most cells cannot adhere to membrane materials, let alone withstand the continuous shear stress of fluid flow.

Choosing a coating is a delicate balance of biological fidelity, reproducibility, and cost. Below, we break down five most commonly used coating strategies found in peer-reviewed literature to help you get started in selecting the right match for your model.

1. The Natural Baseline: Collagen Type I

Collagen Type I is the most abundant structural protein in the human body and is therefore widely used as a natural baseline coating for organ-on-chip membranes. It is a standard choice for mimicking dense interstitial tissue barriers such as the gut mucosa, dermal layers, and lung alveolar spaces, where epithelial or primary cells require a biologically recognizable surface to attach, proliferate, and maintain tissue-specific functions. As a coating, Collagen I provides broad cell-binding sites that interact with integrin receptors on the cell membrane, supporting cell adhesion, intracellular signaling, viability, and structural organization. Because it is highly accessible, comparatively inexpensive, and can polymerize into 3D hydrogels, it is especially useful for tissue engineering scaffolds, organ-on-chip models, and other bioengineered systems that aim to recreate extracellular matrix-like environments. However, animal-derived Collagen I can show batch-to-batch variability, which may limit standardization in high-throughput or highly regulated applications.

2. The Microvascular Go-To: Fibronectin

Fibronectin is a key coating for organ-on-chip models that involve blood flow, endothelial barriers, immune cell interactions, or tumor microenvironments, making it a go-to choice for advanced biochips such as blood-vessel-, heart-, and tumor-on-a-chip platforms. It is commonly used to line inner fluid channels and support cell attachment on membrane or channel surfaces. As a coating, fibronectin is particularly important for mechanotransduction, helping endothelial cells sense fluid shear stress and align naturally in the direction of flow to create physiologically relevant vascular models. In tumor-on-a-chip devices, this versatile matrix protein plays a dual role: it recreates the dense extracellular matrix of the tumor stroma to study cancer cell invasion and serves as the critical vascular interface for modeling tumor angiogenesis and metastasis. At the same time, coating density must be carefully controlled, because excessive fibronectin concentrations can promote overly aggressive cell migration, unintended remodeling, or shifts away from a stable phenotype.

3. The Gold Standard for Complexity: Matrigel

Matrigel is a complex basement membrane extract derived from mouse sarcoma, widely used as a biologically rich 3D matrix and coating for organ-on-chip models. Packed with laminin, collagen IV, and native growth factors, it provides essential survival and differentiation cues that simple, single-protein coatings lack. This makes it the gold standard for sensitive cell sources, including patient-derived organoids, primary cells, stem-cell cultures, and cancer biopsies. Within microfluidic platforms, Matrigel can anchor 3D tumor spheroids, guide blood vessel sprouting (angiogenesis), and model invasive cancer cell behaviors under fluid flow. Its biological complexity replicates the native tumor stroma and basement membrane. However, its undefined composition and batch-to-batch variability present distinct challenges. Because it degrades under strong cellular traction forces and originates from murine tumors, it can introduce non-human artifacts. These limitations ultimately restrict its use in highly regulated drug-discovery workflows and personalized medicine applications, where defined, human-origin recombinant matrices are preferred.

4. Human Recombinant Proteins: The “animal-free” option

Human recombinant proteins, such as human recombinant Collagen I, human Fibronectin, and defined human Laminins including LN-521 or LN-111, are increasingly used as animal-free coatings for organ-on-chip models that require high biological relevance and strong reproducibility. They are particularly valuable for high-fidelity human drug-screening assays, advanced blood-brain barrier models, patient-derived iPSC cultures, and primary endothelial cells lining vascular channels, where the goal is to observe human immune, vascular, or barrier responses without interference from mouse- or other animal-derived proteins. As xeno-free coatings, recombinant human proteins reduce animal cross-reactivity and help generate data that more closely reflects human biology, making them especially attractive for translational research, personalized medicine, and regulated drug-discovery workflows. Their main limitation is cost: recombinant human proteins are significantly more expensive than animal-derived alternatives and often require more specific incubation, handling, or gelation protocols to achieve reliable coating performance.

5. Synthetic Hydrogels & Charge Modifiers: Ultimate Control

Synthetic hydrogels and charge modifiers, such as functionalized PEG hydrogels and Poly-D-Lysine (PDL), are useful coatings when organ-on-chip models require maximum reproducibility, chemical stability, and precise control over the cell microenvironment. Unlike animal-derived matrix proteins, these synthetic surfaces can be engineered with defined stiffness, spatial patterning, and surface charge, making them especially valuable for brain-on-chip setups, neural networks, primary neurons, and specialized cells that do not reliably adhere to standard protein coatings. PDL, for example, introduces a positive charge to the chip surface and creates an electrostatically favorable environment for cell attachment without relying on animal proteins. The main advantage of these coatings is their high consistency and tunability, which helps eliminate batch variation and biological decay; however, because they lack inherent extracellular matrix signaling, cells primarily attach through physical or electrostatic interactions rather than through biochemical communication with the substrate.

Where should you start?

This overview, together with published literature on coatings previously used for your specific cell type or organ-on-chip model, should be considered a practical starting point for selecting a membrane coating. Ultimately, however, coating selection remains application-specific and often requires testing of several conditions to identify the solution that best supports cell attachment, viability, function, and model reproducibility in your individual setup.

To provide a practical reference, the table below summarizes coating solutions that have worked reliably in our laboratory for selected cell types and applications.

More interesting articles: